Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Symp. case 88% Improvement Relative Risk Vitamin D for COVID-19  Savitri et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 42 patients in Indonesia Fewer symptomatic cases with higher vitamin D levels (p<0.000001) c19early.org Savitri et al., Annals of the Romanian.., May 2021 Favors vitamin D Favors control

Comparison between Vitamin D Level of Asymptomatic Confirmed Covid-19 Patients with Symptomatic Confirmed Covid-19 Patients in Makassar

Savitri et al., Annals of the Romanian Society for Cell Biology, 25:6
May 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments. c19early.org
Retrospective 42 PCR+ patients in Indonesia, showing significantly higher risk of symptomatic cases with vitamin D deficiency.
This is the 63rd of 196 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 11,637 vigintillion).
risk of symptomatic case, 88.0% lower, RR 0.12, p < 0.001, high D levels 3 of 25 (12.0%), low D levels 17 of 17 (100.0%), NNT 1.1, >20ng/ml.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Savitri et al., 8 May 2021, retrospective, Indonesia, peer-reviewed, 5 authors.
This PaperVitamin DAll
Comparison between Vitamn D Level of Asymptomatic Confirmed Covid-19 Patients with Symptomatic Confirmed Covid-19 Patients in Makassar
Eka Savitri, Indra Irawan, Nova A L Pieter, Abdul Qadar Punagi, Nani Djufri
Vitamin D shows an important role in immune function. However,there is still little analysis regarding the role of vitamin D inpreventing infection and death fromCOVID-19.This researchaimed todetermine vitamin D levels inpatients with confirmed COVID-19. A crosssectional study was conducted. Researcher collected blood fromthemedian cubital vein of COVID-19 patients and examined the vitamin D levels in patients using the ELISA method.This research showed a comparison of serum vitaminD based on clinical manifestations of COVID-19 patients in all subjects. In20 patients with symptomatic COVID-19 clinical manifestations there were 17 patients (85 %) with vitamin Ddeficiency, 3 patients (15 %) with vitamin D insufficiency; To the contrary, there were noasymptomatic COVID-19 patientswith vitamin D deficiency, 18 patients with vitamin D insufficiency, and 4 patients with normal vitamin D levels.There was a significant relationship between the clinicalmanifestations of patients with COVID-19 and the patient's serum vitamin D levels where asymptomatic patientshad higher levels than that of symptomatic patients (p-value with the Chi-square test was 0.000 with p <0.001).In addition, there was a significant difference between vitamin D levels in asymptomatic and symptomatic patients whereserum vitamin D levels were obtained to be higher in the asymptomatic patient group than in thesymptomaticgroup.
References
Ahn, Current Status of Epidemiology, Diagnosis, Therapeutics and Vaccines for Novel Coronavirus Disease 2019 (COVID-19), J. Microbiol. Biotechnol. Page
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity
Alipio, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus, doi:10.2139/ssrn.3571484
Carpagno, Vitamin D defciency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, Journal of Endocrinological Investigation
Cui, Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system, Redox Biol, doi:10.1016/j.redox.2019.101295
Ebadi, Montana, Perspective: improving vitamin D status in the management of COVID-19, Eur J ClinNutr
Gruber-Bzura, Vitamin D and influenza-prevention or therapy?, Int J MolSci, doi:10.3390/ijms19082419
Horani, Nationality, Gender, Age, and Body Mass Index Influences on Vitamin D Concentration among Elderly Patients and Young Iraqi and Jordanian in Jordan, Biochemistry Research International
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit